The news on a trial of an in-development Alzheimer's drug missed the point -- a potential treatment that could help millions. But smart investors read past the headline.
alzheimerDrug trial defies Wall Street's 'wisdom'MSN Money Latest Articles Wed, 06/18/2008 - 23:01
The news on a trial of an in-development Alzheimer's drug missed the point -- a potential treatment that could help millions. But smart investors read past the headline. High hopes for new Alzheimer's drugMarketplace Tue, 06/17/2008 - 13:47
It's got a big name -- bapineuzumab -- but a new Alzheimer's drug could also have a big payoff. With projections in the billions, it could be the highest grossing drug in history. |